Jyothy Labs H1 Profit Dips 68% on Rising Material Costs

Revenue from Operations: Rs 1,533.44 Crore | Net Profit: Rs 58.24 Crore

Reader Takeaway: Management is returning capital via a buyback while addressing sharp profit declines caused by elevated input costs.

What just happened

Jyothy Labs reported a challenging first half for FY27, with net profit falling to Rs 58.24 crore from Rs 184.55 crore in the same period last year. While revenue from operations showed resilience, growing to Rs 1,533.44 crore from Rs 1,487.27 crore, profitability was severely impacted by input expenses. Simultaneously, the board has approved a buyback of over 6.8 million equity shares at a price of Rs 215 per share.

Why this matters

The buyback, valued at Rs 147 crore, represents 1.86% of the total paid-up equity share capital. Since the promoter group has opted not to participate, the buyback exclusively benefits public shareholders. This provides a liquidity event for retail investors during a period of earnings volatility.

The backstory

The core issue facing Jyothy Labs is a significant jump in the cost of materials consumed, which soared to Rs 985.08 crore in H1 FY27, compared to Rs 737.54 crore in H1 FY26. This nearly 34% increase in production costs has substantially compressed the company's operating margins, overshadowing the modest top-line growth.

Risks to watch

Investors should closely monitor future quarterly updates for signs that material cost increases are stabilizing. Persistent inflation in input costs could continue to drag on net profitability if the company lacks the pricing power to pass these costs to consumers.

What to track next

The record date for the buyback is set for November 11, 2026. Investors should track management’s commentary in upcoming earnings calls regarding their strategy to recover margins and whether these cost headwinds are considered structural or transitory.